May 23-25 Flashcards
What are the seven (7) NCPA legislative priorities, per the checklist?
- H.R. 244: MAC Transparency Act [H.R. 244]
- Encourage CMS to Finalize Guidance on DIR [DIR]
- H.R. 793 and S.1190, Ensuring Seniors Access to Local Pharmacies Act [SENIORS]
- S. 314 and H.R. 592, Provider Status Bills [PROVIDER]
- Ensure Access Compounded Medication [COMPOUNDING]
- TRICARE/NDAA [ARMED]
- Ask them to Join the Congressional Pharmacy Caucus [CAUCUS]
What are the three (3) goals of the MAC Transparency Act? [H.R. 244]
- Increase TRANSPARENCY of generic drug payment rates in Part D, FEHB, and TRICARE retail pharmacy programs
- Establish a DEFINITION of a drug pricing standard
- PROTECT patient privacy and choice of pharmacy in Part D, FEHB, and TRICARE retail pharmacy programs
How will H.R. 244 increase transparency of generic drug payments? (3 components) [H.R. 244]
- Disclose the SOURCES used to set MAC prices
- Provide pricing UPDATES at least once every seven days
- NOTIFY pharmacies of any CHANGES in individual drug prices–in advance of the use–of such prices for the reimbursement of claims.
How will H.R. 244 establish a definition of a drug pricing standard? [H.R. 244]
Definition of DRUG PRICING STANDARD specifically includes MAC as the pricing standard in all Part D, FEHB, and TRICARE retail pharmacy programs.
How will H.R. 244 protect patient privacy and choice of pharmacy? (2 components) [H.R. 244]
- Prohibiting a PBM from TRANSMITTING DATA to a PBM-owned pharmacy, unless the patient voluntarily chooses that pharmacy.
- Prohibiting a PBM from requiring that a beneficiary use a retail or mail order pharmacy in which the PBM has an OWNERSHIP INTEREST.
What does DIR stand for? [DIR}
Direct and Indirect Renumeration
What are three categories of DIR fees? [DIR]
- Pay to Play
- Reconciliation
- Performance Metric
What is the current problem with DIR fees? [DIR]
- Plan/PBM does not properly disclose how DIR fees are calculated,
- Obscuring reimbursement; Allows high MAC reporting (defeating MAC transparency); inaccurate Medicare Plan Finder
- Post Point-of-Sale concessions result in interest-free loan from Medicare Trust Fund to Plans.
What does NCPA want from the CMS’s guidance on the “Final 2014 Part D” rule? [DIR]
That pharmacy concessions that can be “reasonably estimated” at the point-of-sale be reflected in the adjudication process.
What are two (2) bills proposed to ensure seniors can access their pharmacy of choice? [SENIORS]
- H.R. 793
2. S. 1190
What is preventing seniors access to their pharmacy of choice? (3 components) [SENIORS]
- PBMs are using preferred pharmacy networks,
- That result in higher copays if patient goes outside of the network,
- But many community pharmacies are never offered a contract anyway.
What are the downsides of the current preferred pharmacy networks? (3 components)[SENIORS]
- In a 2013 study by CMS, it was shown that savings were not proven, and that in at least 1 instance preferred networks were COSTLIER.
- David Eistenstadt, healthcare economist 2014, says ‘any willing pharmacy’ superior to ‘preferred pharmacy;’ reduces cost by promoting COMPETITION.
- CMS study, urban areas 2014, 54% of drug plans failed to meet ‘reasonable access to pharmacy’ – in rural areas, it is worse because Rx is often more than 20 miles away.
What is NCPA seeking to fix the problem with preferred pharmacy networks and senior pharmacy care access? (3 components) [SENIORS]
- H.R 793 and S. 1190 would allow community pharmacies that are located in
- medically underserved areas (MUAs), medically underserved populations (MUPs), or health professional shortage areas (HPSAs)
- to participate in Medicare Part D preferred pharmacy networks
What are two (2) bills proposed to give pharmacists’ provider status in health professional shortage areas (HPSA)? [PROVIDER]
- H.R. 592
2. S. 314
What do H.R. 592 and S. 314 change? (4 components)[PROVIDER]
- amending Social Security Act,
- to allow Pharmacists to be recognized as providers under Medicare Part B.
- at reimbursement for 85% of physician fee schedule
- Without expanding services beyond scope given by State pharmacy laws.